Decision models can synthesize evidence from different sources to provide estimates of long-term consequences of a decision with uncertainty. Cohort state-transition models (cSTM) are decision models commonly used in medical decision making because they can simulate hypothetical cohorts' transitions across various health states over time. This tutorial shows how to conceptualize cSTMs in a programming language environment and shows examples of their implementation in R. We illustrate their use in a costeffectiveness analysis of a treatment using a previously published testbed cSTM. Both time-independent cSTM where transition probabilities are constant over time and time-dependent cSTM where transition probabilities vary over time are represented. For the time-dependent cSTM, we consider transition
Introduction
Healthcare policy makers are frequently faced with decisions about how to allocate healthcare resources under constrained budgets. These decisions are often informed by health economic evaluations that rely on decision models to synthesize evidence from different sources and project long-term outcomes of different alternatives.
A commonly used decision model is the cohort state-transition model (cSTM), often called a Markov model. 1 In a recent review of R modeling packages, we illustrated the increased utilization of the statistical programming framework R in health decision sciences and provided a collection of resources for its application in medical assumed to be homogeneous (i.e., they all have the same characteristics at the beginning of the simulation), differing only in their current health state. That is, all persons residing in a particular health state are indistinguishable from one another. The cohort can transition between health states with defined probabilities, called "transition probabilities". A transition probability represents the chance that individuals in the cohort residing in a state in a given cycle, transition to another state or remain in the same state for the next cycle.
Transition probabilities only depend on the current health state in a given cycle and do not depend on the history prior to that cycle, which is often referred to as the "Markovian assumption". [10] [11] [12] This means that in a cSTM, transition probabilities do not depend on the history of past transitions or time spent in a given state (i.e., state residence). cSTMs are classified as either time-homogeneous (time-independent) or time-inhomogeneous (time-dependent).
Time-independent cSTMs have constant transition probabilities (i.e., the probability of any state transition is independent of time), while time-dependent cSTMs have transition probabilities that vary over time (i.e., the probability of any state transition is dependent of time). Time-independent models are simpler to implement than time-dependent but most problems in healthcare are best modeled with time-dependent cSTMs because they can capture the increasing age-specific background mortality as the cohort ages (age dependency) and dependency on the amount of time spent in a given state (state residence). In this tutorial, we will first cover time-independent models and will expand them to account for both age and state residence dependency.
In the next sections, we will illustrate the conceptualization and implementation of a cSTM in R to conduct a cost-effectiveness analysis (CEA) using an illustrative example described in the next section. Researchers can easily then customize this application to their own needs.
Case study: Sick-Sicker model
We illustrate the implementation of a cSTM for a CEA using a previously published 4-state Sick-Sicker model. 13, 14 The model is used to quantify the expected costs and quality-adjusted life years (QALYs) for individuals at risk of a hypothetical disease with two different stages, "Sick" and "Sicker". We then evaluate the cost-effectiveness of a hypothetical treatment that improves quality of life (QoL) for those in the Sick state. 8 We use the Sick-Sicker model to illustrate both time-independent and time-dependent cSTMs. For the time-dependent model, we first consider age dependency and expand it to also account for state residence dependency. All the parameters of the Sick-Sicker model and the corresponding R variable names are presented in Table 1 and follow the notation described in the DARTH coding framework. 15 Briefly, we define variables by <x>_<y>_<var_name>, where x indicates the data type [e.g., scalar (no prefix), vector, matrix, data frame], y is the variable type (e.g., probability, rate, relative risk, cost, utility, etc.), and var_name is some description of the variable presented separated by underscores. For example, c_Trt denotes the cost of the treatment where c_ refers to cost followed by the variable name Trt. In later sections we will define all the naming of all the other parameters.
In the Sick-Sicker model, we simulate a hypothetical cohort of 25-year-old individuals over a lifetime (until a maximum age of 110 years old) who all start in the "Healthy" health state (denoted "H"). This means that we will simulate the cohort for 85 cycles. The total number of cycles is denoted as n t and defined in R as n_t.
Healthy individuals are at risk of developing the disease, at which point they transition to the "Sick" health state (denoted by "S1"). Individuals that become sick incur a one-time utility decrement of 0.01 (du_HS1, disutility of transitioning from H to S1) and a transition cost of $1,000 (ic_HS1) that reflects the acute impacts of developing the illness. Sick individuals are at risk of further progressing to a more severe disease stage, the "Sicker" health state (denoted by "S2"). In the time-independent model, the risk of progressing from Sick to Sicker is constant and in the time-dependent model, this risk is a function of the duration of time spent in the Sick state. Individuals in the Sick state can recover and return to the Healthy state.
However, once individuals reach the Sicker state, they cannot recover; that is, the probability of transitioning to the Sick or Healthy health states from the Sicker health state is zero. Individuals in the Healthy state face background mortality that could be either constant for the time-independent model or age-dependent for the time-dependent model. For the age-dependency, Sick and Sicker individuals face an increased mortality compared to Healthy individuals in the form of a hazard ratio (HR) of 3 and 10, respectively, relative to the background mortality rate. Sick and Sicker individuals also experience increased health care costs (in addition to the one-time cost of $1,000) and reduced QoL compared to healthy individuals. Once simulated individuals die, they transition to the absorbing "Dead" state (denoted by "D"), where they remain, and incur a one-time cost of $2,000 (ic_D) that reflects the acute care that might be received immediately preceding death. The state-transition diagram of the Sick-Sicker model is shown in Figure 1 . The evolution of the cohort is simulated in one-year discrete-time cycles. Both costs and QALYs are discounted at an annual rate of 0.03%. We are interested in evaluating the cost-effectiveness of a hypothetical new treatment for individuals affected with the disease compared to usual care (the status quo). The treatment costs $12,000 per year (c_Trt).
The effect of this new treatment is an increase in the QoL of individuals in the Sick state from 0.75 (utility without treatment, u_S1) to 0.95 (utility with treatment, u_Trt). Treatment does not have any impact on the QoL of individuals in the Sicker state, nor does it change the risk of becoming sick or progressing through the sick states. We assume that it is not possible to distinguish between Sick and Sicker patients; therefore, individuals in both sick states receive the treatment. Note that the transition probabilities of the cSTM for the new treatment strategy is structurally identical to that of the usual-care strategy. The only difference is the added cost of the treatment for those in the Sick or Sicker state and the increase in QoL for those in the Sick state. After comparing the two strategies in terms of expected QALYs and costs, we calculate the incremental cost per QALY gained of treatment compared to usual care. Below, we show how to input the parameters in R. All the code is stored as a GitHub repository at https: //github.com/DARTH-git/Cohort-modeling-tutorial. We use the prefixes "v_", "m_" and "a_" to represent a vector, a matrix and a multidimensional array, respectively, consistent with the DARTH framework. To compute the mortality risks from the Sick and Sicker states, we transform p_HD to a rate assuming a constant exponential rate, -log(1 -p_HD), multiply it by the hazard ratios hr_S1 and hr_S2, respectively, and then convert back. See the R code below for more details on the calculations. 
Conceptualizing a cSTM
In general, a cSTM consists of four core components: (1) a state vector, m t , that stores the distribution of the cohort across all health states in cycle t where t = 0, . . . , n t ; (2) the cohort trace matrix, M , that stores the distribution of the cohort over time and is simply the collection of m t for all t; and (3) a transition probability matrix, P t . 16 If the cSTM is comprised of n s discrete health states, m t is a 1 × n s vector and P t is a n s × n s matrix. The i-th element of m t represents the proportion of the cohort in the i-th health state in cycle t, referred to as m [t,i] . Thus, m t is written as
The elements of P t are the transition probabilities of moving from state i to state j, potentially as a function of time t, p [i,j,t] , where {i, j} ∈ 1, . . . , n s and t = 0, . . . , n t
Note that all rows of the transition probability matrix in each cycle t must sum to one, ns j=1 p [i,j,t] = 1 for all i = 1, . . . , n s and t = 0, . . . , n t .
The state vector at cycle t + 1, m t+1 is then calculated by the inner product of the state vector at cycle t, m t , and the transition probability matrix that the cohort faces in cycle t, P t , such that,
where m t is initialized at m 0 , which represents the initial state vector with the proportion of the cohort distributed across all health states at the start of the simulation that begins at cycle 0.
The cohort trace matrix, M , is a matrix of dimensions (n t + 1) × n s where each row is a state vector (−m t −)
M is a commonly used matrix to store the output of cSTM, which could be used to produce epidemiological outcomes, such as prevalence and survival, and economic outcomes, such as cumulative resource use and costs. Note that the initial cycle corresponds to t = 0, which is stored on the first row of M . Table 2 shows a description of each of the core components of cSTM and their suggested name in R code. # Store the initial state vector in the first row of the cohort trace
Note that the initial state vector, v_s_init, can be modified to account the distribution of the cohort across the states at the start of the simulation.
Time-independent cSTM
In a time-independent cSTM, transition probabilities are constant (i.e., do not vary over time). Thus, [1, 1] p [1, 2] · · · p [1,ns] p [2, 1] p [2, 2] 
and m t+1 = m t P .
Since the Sick-Sicker model consists of 4 states, we create a 4 × 4 transition probability matrix, m_P. We initialize the matrix with default values of zero for all transition probabilities and then populate it with the corresponding transition probabilities. To access an element of m_P, we specify first the row number (or name) and then the column number (or name) separated by a comma. For example, the transition probability of going from state Healthy (H) to state Sick (S1) could be accessed by m_P [1, 2] or by using the corresponding row/column state names as characters m_P["H", "S1"].
## Initialize transition probability matrix m_P <-matrix(0, nrow = n_states, ncol = n_states, dimnames = list(v_n, v_n)) # define row and column names
m_P["S1", "H"] <-p_S1H m_P["S1", "S1"] <-1 -(p_S1H + p_S1S2 + p_S1D) m_P["S1", "S2"] <-p_S1S2 m_P["S1", "D"] <-p_S1D
Next, to obtain the cohort distribution across the 4 states over 85 cycles using a time-independent cSTM, we iteratively compute the inner product between m_M and m_P using the inner product %*% symbol in R at each cycle using a for loop Table 3 shows the cohort trace matrix of the Sick-Sicker model for the first six cycles. The whole cohort starts in the Healthy state and transitions to the rest of the health states over time. Given that the Dead state is an absorbing state, the proportion in this state increases over time. A graphical representation of the cohort trace for all the cycles is shown in Figure 2 . 
Time-dependent cSTM
Time-dependency in cSTMs means that transition probabilities vary over time (i.e., the probability of any state transition is dependent of time). Time-dependency in the transition probabilities of cSTMs is a frequently encountered scenario and it can occur in at least two forms: (1) dependence on the time since model start (e.g., age-specific background mortality) in at least one of the health states and (2) dependence on the duration spent in a state (i.e., state-residence). In the next sections, we describe both types of time-dependency and provide a description of their implementation in R.
Time dependency since model start
Transition probabilities that depend on the duration since model start are accounted by the transition probability matrix being a function of time, P t . To illustrate the implementation of time-dependency cince model start in the Sick-Sicker cSTM, we assume that all-cause mortality is a function of age. It is common to obtain all-cause mortality from life tables in the form of age-specific mortality rates, µ(a), where a refers to age. For this example, we create a vector v_r_mort_by_age of length n t with the age-specific background mortality rates obtained from the 2015 US life-tables 17 , corresponding to the age of the cohort at each cycle.
To compute the transition probability from Healthy to Dead for the Sick-Sicker model, we need to transform µ(a) to a transition probability assuming constant exponential rate within each year of age
where a 0 = 25 is the starting age of the cohort. We will run the Sick-Sicker model for 85 cycles; therefore, we select the background mortality rates for ages 25 to 110 by indexing v_r_mort_by_age. Thus, the variable in R is constructed as # Age-specific mortality risk in the Healthy state (background mortality)
Because mortality in the Sick and Sicker health states are defined relative to the background mortality, adding age dependency on background mortality results in age dependent mortality in all health states.
To generate the age-specific mortality for all cycles, we multiply the age-specific background mortality rate, v_r_mort_by_age, by the constant hazard ratios hr_S1 and hr_S2, respectively, and then convert the resulting stage-specific mortality rates to probabilities as described previously.
# Age-specific mortality risk in the Sick state
One way to incorporate age-dependency into the transition probability matrix, P t , is to expand the dimensions of the matrix and create a 3-dimensional transition probability array, a_P, of dimensions n s × n s × n t , where the first two dimensions correspond to transitions between states and the third dimension to time. That is, the t-th element in the third dimension corresponds to the transition probability matrix at cycle t. A visual representation of a_P is shown in Figure 3 . a_P["S1", "H", ] <-p_S1H a_P["S1", "S1", ] <-1 -(p_S1H + p_S1S2 + v_p_S1Dage) a_P["S1", "S2", ] <-p_S1S2 a_P["S1", " To simulate the cohort over the n t cycles for the age-dependent cSTM, we initialize a new cohort trace matrix When addressing dependency on state residence with tunnels states, we produce as many states as timedependency is desired. For example, if dependency in a given state is assumed for T cycles, such state needs to be expanded T times. This will generate an expanded transition probability matrix (or array if time since model start matters too) of dimensions n s T × n s T (or n s T × n s T × n t ), where n s T is the total number of health states after accounting for the expansion of a given state for T tunnel states. Dependency to state residence could occur for as many as n t − 1 cycles. Figure 5 shows the state-transition diagram of the Sick-Sicker model that includes state residence dependency with T tunnel states for S1. Figure 5 : State-transition diagram of the Sick-Sicker model with tunnel states expanding the Sick state (S1 1 , S1 2 , ..., S1 τ ).
Time dependency based on state residence
To illustrate state residence dependency in the age-dependent Sick-Sicker model defined above, we assumed that the risk of progression from Sick to Sicker increases the longer a person has been sick. This increase follows a Weibull growth curve, defined as
where τ = 1, . . . , T is the τ -th cycle (year) that a person has been in the Sick state, and λ and γ are the scale and shape parameters of the Weibull function, respectively. We assume that state residence dependency occurs throughout the whole simulation (i.e., T = n t ) and create a new variable called n_tunnel_size with the length of the tunnel equal to n_t. Thus, there will be 85 S1 tunnel states plus 3 more states (H, S2, D)
resulting in a total of n s T = 88. To implement the transition probability array for the age-and state-residence-dependent Sick-Sicker model, we create an expanded 3-dimensional array accounting for tunnels a_P_tunnels of dimensions n s T × n s T × n t ,
where n s T = 88, is the number of states of the Sick-Sicker model with tunnels. A visual representation of a_P_tunnels of the Sick-Sicker model with tunnel states expanding the Sick state is shown in Figure 6 . 
Epidemiological and economic outputs
cSTMs can be used to generate different epidemiological and economic outputs. In CEA, the final outcomes are typically the total expected QALYs and costs accrued in the cohort over the chosen time horizon. However, epidemiological outcomes are often used for different purposes such as calibration and validation. Some common epidemiological outcomes include survival, prevalence, incidence, average number of events and lifetime risk events. 3 Below, we provide the epidemiological definition of some of these outcomes and how they can be calculated from a cSTM using the age-dependent Sick-Sicker cSTM as an example.
Epidemiological outcomes

Survival curve
The survival curve, S(t), is defined as the proportion of the population alive at cycle t. To estimate S(t) from the simulated cohort of the age-dependent Sick-Sicker model, we sum the proportions of the non-death states for all n t cycles in m_M_ad.
v_S_ad <-rowSums(m_M_ad[, -4]) # vector with survival curve
and is shown in Figure 8 . 
Prevalence
Prevalence is defined as the proportion of those having a specific condition (or being in a specific health state) out of those in the living population at risk of experiencing the condition of interest. 18 To calculate the prevalence of S1 at cycle t, prev(t) i , we compute the ratio between the proportion of the cohort in S1 and the proportion alive at that cycle. 19 The proportion of the cohort alive is given by the survival curve S(t) defined above. The individual prevalence of the S1 and S2 health states, and the overall prevalence of sick individuals (i.e., S1 and S2) of the age-dependent Sick-Sicker cSTM at each cycle t is computed as follows and are shown in Figure 9 . Health State S1 S2 S1 and S2 Another epidemiological outcome that could be of interest, is the proportion of Sicker (i.e., S2) among the sick individuals. To compute the proportion of S2 among all sick individuals at each cycle t, we divide m [S2,t] by prev(t) {S1,S2} where t > 0, as presented in Figure 10 . Note that t does not start at 0 because it takes one cycle for the cohort to get sick. 
# Vector with proportion of Sicker among sick individuals
Life expectancy
Life expectancy (LE) refers to the expected number of years remaining to be lived. 20 LE is the area under the survival curve S(t). 21 In discrete time, LE is calculated as
In the age-dependent Sick-Sicker model, where we simulated a cohort over 85 cycles, life expectancy le_ad is 41.1, which is calculated as follows le_ad <-sum(v_S_ad) # life expectancy 6 State and transition rewards
State rewards
A state reward refers to a value assigned to individuals for being in a given state. In a cost-utility context, these could be either utilities or costs associated with remaining in a certain health state for one cycle. The total expected reward of an outcome of interest for the entire cohort at each cycle can be stored in the column vector y of size (n t + 1). To calculate y, we simply multiply the cohort trace matrix times a vector of state rewards r of the same dimension as the number of states (n s )
Note that rewards can also be time-or age-dependent; in such cases, the vector of state rewards will be time-dependent, r t . For the Sick-Sicker model, we create a vector of utilities and costs under usual care, v_u_UC and v_c_UC, respectively. Each of these vectors contain the utilities and costs corresponding with being in each of the four health states under usual care, which are shown in Table 1 . To create the vector of state costs under the new treatment, v_c_Tr, we add the cost of treatment, c_Trt, to the state costs of S1 and S2.
# Vector of state costs under new treatment
v_c_Tr <-c(H = c_H, S1 = c_S1 + c_Trt, S2 = c_S2 + c_Trt, D = c_D)
To compute the expected QALYs and costs for the age-dependent Sick-Sicker model under usual care and new treatment for all cycles, we apply Eq. (1) by multiplying the cohort trace matrix, m_M_ad, times these vectors. To account for discounting, the generated rewards per cycle are multiplied by the cycle specific discount weight. The vector of expected rewards, y, is multiplied by a discounting column vector d of size n t + 1
where each of its t-th entry represents the discounting for cycle t
where d is the cycle-length discount rate. Therefore, the total expected discounted outcome over the n t cycles, y, is obtained by the inner product between y transposed, y , and d, y = y d.
(
The discount vectors for costs and QALYs for the Sick-Sicker model, v_dwc and v_dwe, respectively, are 
Transition rewards
In addition to the state rewards (e.g., costs and utilities associated with residing in a given state), a transition from one state to another may in of itself be associated with a one-time cost or utility impact, termed a "transition reward". For example, in the Sick-Sicker model, we previously mentioned that dying (i.e., transitioning to the Dead state) incurs a one-time cost of $2,000 that reflects the acute care that might be received immediately preceding death. This could include emergency services, hospitalization, or other healthcare utilization to address the ultimately fatal health complication. We also include a utility decrement and a cost increment on the transition from the Healthy to Sick states. Whereas the cost and utility of the Sick state reflects the ongoing cost and utility of being chronically sick, transition rewards capture the short-term impact of the acute events of becoming sick, such as hospitalization, stabilization, and so on.
To include transition rewards on the calculation of the total expected reward of an outcome of interest, y, we replace the vector of state rewards r with a matrix of rewards R t of dimensions n s × n s , and the cohort trace matrix, M , with a multidimensional array A, of dimensions n s × n s × [n t + 1], called the transition-dynamics array. 22 Briefly, A stores the proportion of the cohort that transitions between any two health states in each cycle over the time horizon, and R t contains the rewards associated with transitioning between states -including remaining in a state-at cycle t. For a more detailed description of the transition-dynamics array and matrix of rewards, please see Krijkamp et al. (2020) 22 .
To compute A for the age-dependent Sick-Sicker model, we initialize a three-dimensional array a_A of dimensions n s × n s × [n t + 1] and set the diagonal of the first slice to the initial state vector v_s_init. 
# Set first slice of A equal to the initial state vector in its diagonal diag(a_A[, , 1]) <-v_s_init
We then iterate the element by element multiplication between each of the rows of the cohort trace matrix, m_M_ad, and the array of transition matrices, a_P, for each cycle to estimate all transitions between all states over all n t cycles.
# Iterative solution to produce the transition array
To create the arrays of rewards for costs and utilities for the Sick-Sicker cSTM, we create strategy-specific arrays of rewards because the new treatment affects both outcomes. We use the aperm function as a shortcut to order the rewards such that each of the rows across the third dimension of these arrays are filled with the vector of state rewards. To account for the transition rewards, we either add or subtract them in the corresponding location of the reward matrix that represents the transitions of interest. For example, to account for the disutility of transitioning from H to S1 on the Treatment strategy, we subtract the disutility to the entry of the array of rewards corresponding to the transition from H to S1 across all cycles.
# Add disutility due to transition from Healthy to Sick a_R_u_Tr["H", "S1", ] <-a_R_u_Tr["H", "S1", ] -du_HS1
In a similar approach, we add the costs of transitioning from H to S1 and the cost of dying for the treatment strategy.
# Add transition cost due to transition from Healthy to Sick a_R_c_Tr["H", "S1", ] <-a_R_c_Tr["H", "S1", ] + ic_HS1 # Add transition cost of dying from all non-dead states Below, we show how the transition rewards are added to the reward matrices corresponding to usual care.
# Add disutility due to transition from H to S1
a_R_u_UC["H", "S1", ] <-a_R_u_UC["H", "S1", ] -du_HS1 # Add transition cost due to transition from H to S1 a_R_c_UC["H", "S1", ] <-a_R_c_UC["H", "S1", ] + ic_HS1 The state and transition rewards are applied to the model dynamics by element-wise multiplication between A and R, indicated by the sign, which produces the array of outputs for all n t cycles, Y. Formally,
To obtain Y for all the QALYs and costs for both strategies, we apply Equation (3) The total rewards for each health state at cycle t, t t , is obtained by summing the rewards across all j = 1, ..., n s health states for all n t cycles.
To obtain the expected costs and QALYs per cycle for each strategy, y, we apply again Equation (4) t(colSums(a_Y_c_Tr) ))
The total expected discounted (TED) costs and QALYs, y, is obtained by applying Equation (1) 
Effect (QALYs)
Cost ($)
Efficient Frontier Figure 11 : Cost-effectiveness effcicient frontier of the new treatment vs. usual care for the age-dependent Sick-Sicker model.
Discussion
In this tutorial, we provided a conceptualization of cSTMs with their mathematical description and a walk-through of their implementation for CEA in R using a previously published example. We used R as the programming language of choice to show the implementation of these models with accompanying code throughout the tutorial. We describe both time-independent and time-dependent models. We showed two different implementations of the time-dependent model, accounting for transition probabilities that depend on time since model start (e.g., age dependence) and on state residence.
We focused on discrete-time matrix-form cSTMs but continuous-time models or implemented via a set of difference equations 23, 24 could also be implemented in R. We refer readers interested in learning more on continuous-time cSTMs to previously published papers 25-28 and a tutorial using R. 29 We should note that a number of alternative approaches can be applied in the incorporation of time-dependency in cSTM in R and in a programming language in general. For example, another approach to incorporate age-dependency involves the updating of the time varying elements of the transition probability matrix P t at each time point t. That would alleviate the need for the construction of the array a_P. This can reduce computer memory requirements, but at the expense of increasing the number of operations in the update of P t at every cycle. Another approach to account for state residence dependency, is to also use a 3-dimensional transition probability matrix with dimensions for current state, future state, and time in current state. 30 However, to incorporate age dependence, this multidimensional matrix will have to be expanded by another dimension or the states will have to be replicated for as many age groups are considered in the model. In this tutorial we decided to use the third dimension as the age of the cohort and incorporate state residence dependency by expanding the corresponding health states on the second dimension of the 3-dimensional to account for time spent in current state. A benefit of this approach is that we can use the transition dynamics array to capture all transitions between all states for all cycles.
cSTMs are recommended when the number of states is "not too large". 3 
